Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2021 · 112.5K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Improved Survival with Bevacizumab in Advanced Cervical Cancer

Krishnansu S. Tewari, Michael W. Sill, Harry J. Long et al. · New England Journal of Medicine · 2014 · 1.5K citations · Full text

Medicine, Oncology, Pharmacology +15

HPV Vaccination and the Risk of Invasive Cervical Cancer

Jiayao Lei, Alexander Ploner, K. Miriam Elfström et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

Medicine, Oncology, Preventive Medicine +17

Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study

Hyun Cheol Chung, Willeke Ros, Jean‐Pierre Delord et al. · Journal of Clinical Oncology · 2019 · 1.1K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors

Gregory T. Motz, Stephen P. Santoro, Liping Wang et al. · Nature Medicine · 2014 · 1K citations · Full text

Medicine, Immunology, Oncology +14